Australia
Cartherics grants Shunxi Licence for CAR-T Cell Therapy for Ovarian Cancer in Greater China
CTH-004 has shown promising results in animal models of ovarian cancer and will be evaluated in a clinical trial under a research and development...
April 28, 2023 | News
Telix Accelerates Artificial Intelligence (AI) Development Program with Acquisition of Dedicaid
Dedicaid's core asset is a clinical decision support software (CDSS) AI platform capable of rapidly generating indication-specific CDSS applications from a...
April 27, 2023 | News
Bridgewest Perth Pharma to commercialize Sterile Injectable drugs under LumaCina business unit
The newly created business leverages the acclaimed team and production facility recently acquired by Bridgewest Group from Pfizer (Perth) Pty Ltd, a subsid...
April 26, 2023 | News
Cytiva supports BioCina with first GMP production and development facility for mRNA in Australia
Expanded facility to manufacture mRNA-based therapies and vaccines Researchers at the University of Adelaide will address the design and ma...
April 26, 2023 | News
Why Pharma and Medtech manufacturers are striving for digital maturity
Why pharma and medtech manufacturers are striving for...
April 25, 2023 | News
500 women join Australia's landmark maternity medical device study
The study was led by Principal Investigators Professor Michael Nicholls, Professor Andrew Bisits and Michelle de Vroom at two Aust...
April 20, 2023 | News
University of Technology Sydney researchers develop ground-breaking heart failure treatment using 3D-printed heart tissue
Researchers from The University of Technology Sydney (UTS) have demonstrated that 3D bioprinted heart tissues can safely and effectively help patients reco...
April 20, 2023 | News
Nona Biosciences and Washington University Join Forces to Tackle Emerging RNA Viruses
"This collaboration represents an exciting opportunity for Nona Biosciences to leverage its fully human antibody H2L2 transgenic mice, together with the te...
April 19, 2023 | News
Bone Biologics Gets Approval for Pilot Clinical Trial with NB1 for Spinal Fusion in Australia.
Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, announces that the Human Research Ethics Committ...
April 13, 2023 | News
MIM Software Celebrates MTIC's First Total-Body PET/CT Scanner
MIM Software Inc., a leading global provider of medical imaging software, is proud to support the efforts of the Melbourne Theronastic Innovation Centre (M...
April 13, 2023 | News
Partnership agreement to commercialize new anti-PD1 antibody in Australia and Southeast Asia signed by Specialised Therapeutics
The therapy ANNIKO® (penpulimab) is an anti-PD1 monoclonal antibody currently under regulatory review by the US FDA for nasopharyngeal carcinoma &...
April 12, 2023 | News
Chinese NMPA Approves Study of Telix Brain Cancer Therapy Candidate
The investigational new drug (IND) application was submitted by Telix's partner in the Greater China region, Grand Pharmaceutical Group Limited (...
April 11, 2023 | News
TrialWire Patient Recruitment Platform Launches AI Pre-recruit to Cut Recruitment Time by 50%
Pre-recruit ensures study sites have patients to contact as soon as the sites are activated, saving weeks or even months on a clinical program. Real-world ...
April 11, 2023 | News
Bridgewest Group launches NovaCina, new sterile injectable CDMO
The newly acquired facility and team is in Bentley, a suburb of Perth in Western Australia. It will operate as a Contract Development and Ma...
April 05, 2023 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
